Cargando…

Melanoma-intrinsic β-catenin signaling prevents T cell infiltration and anti-tumor immunity

Detalles Bibliográficos
Autores principales:	Spranger, Stefani, Bao, Riyue, Gajewski, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288324/ http://dx.doi.org/10.1186/2051-1426-2-S3-O15

Ejemplares similares

Immune surveillance is thwarted by tumor-cell intrinsic beta-catenin signaling
por: Spranger, Stefani, et al.
Publicado: (2015)

Therapeutic efficacy of combined blockade of CTLA-4 +/- PD-L1 +/- IDO is associated with re-activation of T cells directly within the tumor microenvironment
por: Spranger, Stefani, et al.
Publicado: (2013)

Agonist anti-4-1BB plus neutralizing anti-CTLA-4 or -PD-L1 synergize to promote tumor regression by rescuing dying dysfunctional CD8+ T cells within the tumor microenvironment
por: Horton, Brendan, et al.
Publicado: (2015)

A new paradigm for tumor immune escape: β-catenin-driven immune exclusion
por: Spranger, Stefani, et al.
Publicado: (2015)

Evidence implicating the commensal microbiota in shaping anti-tumor immunity in melanoma
por: Sivan, Ayelet, et al.
Publicado: (2014)

The genetic landscape of the T cell non-inflamed tumor microenvironment in human solid tumors
por: Luke, Jason J, et al.
Publicado: (2015)

Characterization of oncogenic pathways linked with T cell exclusion in urothelial bladder cancer
por: Sweis, Randy F, et al.
Publicado: (2015)

Density of immunogenic antigens does not explain presence or absence of the T cell-inflamed tumor microenvironment in metastatic melanoma
por: Zha, Yuanyuan, et al.
Publicado: (2015)

Tumor-intrinsic oncogene pathways mediating immune avoidance
por: Spranger, Stefani, et al.
Publicado: (2015)

Secondary resistance to immunotherapy associated with β-catenin pathway activation or PTEN loss in metastatic melanoma
por: Trujillo, Jonathan A., et al.
Publicado: (2019)

Modulation of the immune microenvironment by tumor-intrinsic oncogenic signaling
por: Nguyen, Kim Bich, et al.
Publicado: (2019)

Tumor-infiltrating lymphocytes predict cutaneous melanoma survival
por: Fortes, Cristina, et al.
Publicado: (2015)

Extremely potent immunotherapeutic activity of a STING agonist in the B16 melanoma model in vivo
por: Corrales, Leticia, et al.
Publicado: (2013)

Revealing cancer initiating cells in metastatic melanomas by harnessing the host′s anti tumor humoral immune mechanisms
por: Kotlan, Beatrix, et al.
Publicado: (2014)

Wilms tumor reveals DNA repair gene hyperexpression is linked to lack of tumor immune infiltration
por: Higgs, Emily F, et al.
Publicado: (2022)

Anti-tumor antibody profile analysis to harness the potentials of B cells in melanomas and the natural humoral immune response
por: Kotlan, Beatrix, et al.
Publicado: (2013)

Agonistic 4-1bb antibodies in combination with inhibitory antibodies against CTLA-4, PD-L1 or LAG-3 ACT on CD8+ T cells in the tumor microenvironment and synergize to promote regression of established tumors
por: Horton, Brendan, et al.
Publicado: (2014)

Virus-specific CD8+ T cells infiltrate melanoma lesions and retain function despite high PD-1 expression
por: Erkes, Dan A, et al.
Publicado: (2015)

FcgRIIIA (CD16)-expressing monocytes mediate the depletion of tumor-infiltrating Tregs via Ipilimumab-dependent ADCC in melanoma patients
por: Romano, Emanuela, et al.
Publicado: (2014)

Regulation of melanoma initiating cells by Hedgehog signaling and SOX2
por: Santini, Roberta, et al.
Publicado: (2014)

Peripheral and tumor immune correlates in patients with advanced melanoma treated with nivolumab (anti-PD-1, BMS-936558, ONO-4538) monotherapy or in combination with ipilimumab
por: Postow, Michael A, et al.
Publicado: (2014)

Analysis of T and NK cells immune response in Ipilimumab treated Melanoma patients
por: Tallerico, Rossana, et al.
Publicado: (2015)

Systems biology analysis of immune signaling in peripheral blood mononuclear cells (PBMC) of melanoma patients receiving ipilimumab; basis for response biomarker identification
por: Hotson, Drew, et al.
Publicado: (2014)

Role of the Wnt-β-catenin signaling pathway in melanoma-mediated dendritic cell tolerization
por: Holtzhausen, Alisha, et al.
Publicado: (2013)

Innate immune sensing of a growing tumor in vivo occurs via the host sting pathway and involves mitochondrial DNA transfer from cancer cells to DCs
por: Woo, Seng-Ryong, et al.
Publicado: (2013)

Biomarker analysis of on-treatment and at progression biopsies from BRIM7 - a phase 1B trial of combined vemurafenib and cobimetinib treatment in BRAF V600 mutated melanoma
por: Yan, Yibing, et al.
Publicado: (2014)

De-Escalating Anti-Pseudomonal β-Lactams
por: Catteeuw, J, et al.
Publicado: (2015)

Updated results and correlative FDG-PET analysis of a phase IB study of vemurafenib and cobimetinib (MEK inhibitor [GDC-0973]), in advanced BRAF(V600)- mutated melanoma (BRIM7)
por: Puzanov, Igor, et al.
Publicado: (2014)

Energetics of the intrinsic foot muscles in plantar fasciitis
por: Chang, R, et al.
Publicado: (2008)

HIV-1 antagonism of CD317/tetherin is species-specific and involves Vpu-mediated proteasomal degradation of the intrinsic immunity factor
por: Goffinet, Christine, et al.
Publicado: (2009)

T-cell mediated immune response to HIFU-induced liquefaction of murine B16 melanoma
por: Khokhlova, Tatiana
Publicado: (2015)

Exploring intrinsic MR signal relaxation in acute RF ablation lesions using T2 mapping and IR-SSFP CINE imaging
por: Ramanan, Venkat, et al.
Publicado: (2013)

Tissue resident memory T cells create genetically distinct immune microenvironments within melanoma metastasis
por: Dhodapkar, Kavita, et al.
Publicado: (2015)

Hematopoietic stem cells have an intrinsic expansion limit
por: Rojas-Sutterlin, Shanti, et al.
Publicado: (2013)

Stromal and epithelial TGF-β signaling in mammary tumorigenesis
por: Moses, HL, et al.
Publicado: (2005)

Stimulus-dependent suppression of intrinsic variability in recurrent neural networks
por: Rajan, Kanaka, et al.
Publicado: (2010)

Innate immunity and the anti-viral state of rheumatoid synovium
por: Firestein, GS
Publicado: (2005)

Cell intrinsic Wnt/β-catenin signaling activation
por: Bernkopf, Dominic B., et al.
Publicado: (2018)

Efficacy of anti-ICOS agonist monoclonal antibodies in preclinical tumor models provides a rationale for clinical development as cancer immunotherapeutics
por: Harvey, Christopher, et al.
Publicado: (2015)

Identification of tumor-intrinsic drivers of immune exclusion in acral melanoma
por: Augustin, Ryan C, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_18e6bgisefdjt3ad4kourjrl18